Degron Therapeutics vs Ternary Therapeutics
Degron Therapeutics vs Ternary Therapeutics, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Degron Therapeutics is on 62/100 and Ternary Therapeutics on 49/100.
Where each one leads
Degron Therapeutics
- our overall score: 62/100 against 49/100
- agent readiness: 27/100 against 22/100
- domain rating: 25/100 against 6/100
- funding raised: $40.0M against $4.3M
Ternary Therapeutics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Degron Therapeutics | Ternary Therapeutics |
|---|---|---|
| What it is | Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines. | AI platform for engineering molecular glues to create a new class of medicines. |
| Category | Biotechnology, Pharmaceuticals, Drug Discovery, Healthcare | Biotechnology, Artificial Intelligence, Drug Discovery, Pharmaceuticals |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2020 | 2024 |
| Headquarters | San Diego, USA | London, United Kingdom |
| Status | Active | Active |
Size, funding and growth
| Measure | Degron Therapeutics | Ternary Therapeutics |
|---|---|---|
| Employees | 24 | Not published |
| Total funding | $40.0M | $4.3M |
| Latest round | Series A Extension | Seed |
| Valuation | $1.1B | Not published |
| LinkedIn followers | 1,380 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Degron Therapeutics | Ternary Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 49/100 |
| Traction | Not published | 33/100 |
| Team | 24/100 | 70/100 |
| Search visibility | 57/100 | 12/100 |
| Quality | Not published | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (27/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 25/100 | 6/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Degron Therapeutics | Ternary Therapeutics |
|---|---|---|
| Hosting | Self Managed | AWS |
| CDN | Not detected | CloudFront |
| Frameworks | Not detected | Bootstrap |
Degron Therapeutics vs Ternary Therapeutics: common questions
Which is better, Degron Therapeutics or Ternary Therapeutics?
On our 0-100 score Degron Therapeutics rates higher (62/100 against 49/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Degron Therapeutics and Ternary Therapeutics compare on the numbers?
Degron Therapeutics leads on our overall score (62/100 against 49/100), agent readiness (27/100 against 22/100), domain rating (25/100 against 6/100), funding raised ($40.0M against $4.3M).
Read the full Degron Therapeutics review and pricing or the Ternary Therapeutics review and pricing. You can also browse other Degron Therapeutics alternatives we track.